[1m[33m#All pubmed ids: 32709258, 32703911, 32709975, 32726885, 32726822, 32726617, 32726445, 32726432, 32726325, 32725539, 32725451, 32725165, 32724874, 32724790, 32724459, 32724444, 32724428, 32724412, 32724403, 32724397, 32724395, 32724376, 32724363[0m

[1m[31mPubmed ID: 32709258[0m

Title: Catabolism and interactions of uncultured organisms shaped by eco-thermodynamics in methanogenic bioprocesses.

Journal: Microbiome (Microbiome)

Date: 2020-Jul

Abstrct_EN: Current understanding of the carbon cycle in methanogenic environments involves trophic interactions such as interspecies H<sub>2</sub> transfer between organotrophs and methanogens. However, many metabolic processes are thermodynamically sensitive to H<sub>2</sub> accumulation and can be inhibited by H<sub>2</sub> produced from co-occurring metabolisms. Strategies for driving thermodynamically competing metabolisms in methanogenic environments remain unexplored. To uncover how anaerobes combat this H<sub>2</sub> conflict in situ, we employ metagenomics and metatranscriptomics to revisit a model ecosystem that has inspired many foundational discoveries in anaerobic ecology-methanogenic bioreactors. Through analysis of 17 anaerobic digesters, we recovered 1343 high-quality metagenome-assembled genomes and corresponding gene expression profiles for uncultured lineages spanning 66 phyla and reconstructed their metabolic capacities. We discovered that diverse uncultured populations can drive H<sub>2</sub>-sensitive metabolisms through (i) metabolic coupling with concurrent H<sub>2</sub>-tolerant catabolism, (ii) forgoing H<sub>2</sub> generation in favor of interspecies transfer of formate and electrons (cytochrome- and pili-mediated) to avoid thermodynamic conflict, and (iii) integration of low-concentration O<sub>2</sub> metabolism as an ancillary thermodynamics-enhancing electron sink. Archaeal populations support these processes through unique methanogenic metabolisms-highly favorable H<sub>2</sub> oxidation driven by methyl-reducing methanogenesis and tripartite uptake of formate, electrons, and acetate. Integration of omics and eco-thermodynamics revealed overlooked behavior and interactions of uncultured organisms, including coupling favorable and unfavorable metabolisms, shifting from H<sub>2</sub> to formate transfer, respiring low-concentration O<sub>2</sub>, performing direct interspecies electron transfer, and interacting with high H<sub>2</sub>-affinity methanogenesis. These findings shed light on how microorganisms overcome a critical obstacle in methanogenic carbon cycles we had hitherto disregarded and provide foundational insight into anaerobic microbial ecology. Video Abstract.

Abstrct_CN: 目前对产甲烷环境中碳循环的认识涉及营养相互作用，例如有机营养物和产甲烷菌之间的种间H <sub> 2 </ sub>转移。然而，许多代谢过程对H <sub> 2 </ sub>的积累是热力学敏感的，并且可以被共生代谢产生的H <sub> 2 </ sub>抑制。在产甲烷环境中驱动热力学竞争性代谢的策略尚未探索。为了揭示厌氧菌如何原位对抗H <sub> 2 </ sub>冲突，我们采用宏基因组学和超转录组学重新审视了一个模型生态系统，该模型生态系统启发了厌氧生态学-甲烷生物反应器中的许多基础发现。通过对17个厌氧消化池的分析，我们为跨越66个门的未培养谱系恢复了1343个高质量的元基因组组装基因组和相应的基因表达谱，并重建了它们的代谢能力。我们发现，不同的未培养种群可以通过（i）代谢耦合与同时发生的H <sub> 2 </ sub>耐受的分解代谢来驱动H <sub> 2 </ sub>敏感的代谢，（ii）放弃H <sub> 2 </ sub>的产生有利于甲酸和电子之间的种间转移（细胞色素和菌毛介导），以避免热力学冲突，以及（iii）将低浓度O <sub> 2 </ sub>代谢整合为辅助热力学增强电子接收器。古细菌种群通过独特的产甲烷代谢支持这些过程-高度有利的H <sub> 2 </ sub>氧化，由甲基还原甲烷生成和甲酸酯，电子和乙酸的三方吸收驱动。组学和生态热力学的整合揭示了未培养生物的行为和相互作用被忽略了，包括良好和不利的新陈代谢耦合，从H <sub> 2 </ sub>转移到甲酸转移，呼吸低浓度O <sub> 2 </ sub >，进行直接的种间电子转移，并与高H <sub> 2 </ sub>亲和性甲烷化相互作用。这些发现揭示了微生物如何克服迄今为止我们所忽略的产甲烷碳循环中的关键障碍，并为厌氧微生物生态学提供了基础知识。录像摘要。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32703911[0m

Title: Can Dietary Fatty Acids Affect the COVID-19 Infection Outcome in Vulnerable Populations?

Journal: mBio (mBio)

Date: 2020-07

Abstrct_EN: There is high mortality in coronavirus disease 2019 (COVID-19)-infected individuals with chronic inflammatory diseases, like obesity, diabetes, and hypertension. A cytokine storm in some patients after infection contributes to this mortality. In addition to lungs, the intestine is targeted during COVID-19 infection. The intestinal membrane serves as a barrier to prevent leakage of microorganisms and their products into the bloodstream; however, dietary fats can affect the gut microbiome and may increase intestinal permeability. In obese or diabetic individuals, there is an increase in the abundance of either Gram-negative bacteria in the gut or their product, endotoxin, in systemic circulation. We speculate that when the COVID-19 infection localizes in the intestine and when the permeability properties of the intestinal membrane are compromised, an inflammatory response is generated when proinflammatory endotoxin, produced by resident Gram-negative bacteria, leaks into the systemic circulation. This review discusses conditions contributing to inflammation that are triggered by microbially derived factors from the gut.

Abstrct_CN: 冠状病毒疾病2019（COVID-19）感染的慢性炎症性疾病（如肥胖症，糖尿病和高血压）的死亡率很高。感染后某些患者的细胞因子风暴可导致这种死亡。除肺外，在COVID-19感染期间还以肠道为目标。肠膜是防止微生物及其产物渗入血液的屏障。然而，膳食脂肪会影响肠道微生物组，并可能增加肠道通透性。在肥胖或糖尿病个体中，肠道中革兰氏阴性细菌或其产物内毒素在系统循环中的丰度增加。我们推测，当COVID-19感染位于肠道内，并且当肠膜的通透性受到损害时，当驻留的革兰氏阴性细菌产生的促炎性内毒素泄漏到体循环中时，就会产生炎症反应。这篇综述讨论了由肠道中微生物衍生的因素触发的促发炎症的疾病。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32709975[0m

Title: Termite mounds contain soil-derived methanotroph communities kinetically adapted to elevated methane concentrations.

Journal: The ISME journal (ISME J)

Date: 2020-Jul

Abstrct_EN: Termite mounds have recently been confirmed to mitigate approximately half of termite methane (CH<sub>4</sub>) emissions, but the aerobic CH<sub>4</sub> oxidising bacteria (methanotrophs) responsible for this consumption have not been resolved. Here, we describe the abundance, composition and CH<sub>4</sub> oxidation kinetics of the methanotroph communities in the mounds of three distinct termite species sampled from Northern Australia. Results from three independent methods employed show that methanotrophs are rare members of microbial communities in termite mounds, with a comparable abundance but distinct composition to those of adjoining soil samples. Across all mounds, the most abundant and prevalent methane monooxygenase sequences were affiliated with upland soil cluster α (USCα), with sequences homologous to Methylocystis and tropical upland soil cluster (TUSC) also detected. The reconstruction of a metagenome-assembled genome of a mound USCα representative highlighted the metabolic capabilities of this group of methanotrophs. The apparent Michaelis-Menten kinetics of CH<sub>4</sub> oxidation in mounds were estimated from in situ reaction rates. Methane affinities of the communities were in the low micromolar range, which is one to two orders of magnitude higher than those of upland soils, but significantly lower than those measured in soils with a large CH<sub>4</sub> source such as landfill cover soils. The rate constant of CH<sub>4</sub> oxidation, as well as the porosity of the mound material, were significantly positively correlated with the abundance of methanotroph communities of termite mounds. We conclude that termite-derived CH<sub>4</sub> emissions have selected for distinct methanotroph communities that are kinetically adapted to elevated CH<sub>4</sub> concentrations. However, factors other than substrate concentration appear to limit methanotroph abundance and hence these bacteria only partially mitigate termite-derived CH<sub>4</sub> emissions. Our results also highlight the predominant role of USCα in an environment with elevated CH<sub>4</sub> concentrations and suggest a higher functional diversity within this group than previously recognised.

Abstrct_CN: 最近已确认白蚁丘可以减轻大约一半的白蚁甲烷（CH <sub> 4 </ sub>）排放，但是尚未引起这种消耗的好氧CH <sub> 4 </ sub>氧化细菌（甲烷）。解决。在这里，我们描述了从北澳大利亚采样的三种不同白蚁物种的土堆中甲烷营养菌群落的丰度，组成和CH <sub> 4 </ sub>氧化动力学。三种独立方法的结果表明，甲烷营养菌是白蚁丘中微生物群落的稀有成员，其丰度可比但与相邻土壤样品的微生物组成截然不同。在所有土丘中，最丰富，最普遍的甲烷单加氧酶序列与山地土壤簇α（USCα）相关，并且与甲基囊藻和热带山地土壤簇（TUSC）同源。土墩USCα代表的基因组组装基因组的重建突显了这一组甲烷营养生物的代谢能力。根据原位反应速率估算了CH <sub> 4 </ sub>在土堆中的表观Michaelis-Menten动力学。群落的甲烷亲和力处于较低的微摩尔范围，比陆地土壤的甲烷亲和力高一到两个数量级，但显着低于CH <sub> 4 </ sub>来源较大的土壤中的甲烷亲和力。垃圾填埋场覆盖土壤。 CH <sub> 4 </ sub>的氧化速率常数以及土堆材料的孔隙率与白蚁土体甲烷营养菌群落的丰富程度呈显着正相关。我们得出的结论是，白蚁衍生的CH <sub> 4 </ sub>排放物已被选择用于不同的甲烷营养生物群落，这些群落在动力学上适应于升高的CH <sub> 4 </ sub>浓度。然而，除底物浓度外，其他因素似乎也限制了甲烷氧化菌的丰度，因此这些细菌只能部分减轻白蚁衍生的CH <sub> 4 </ sub>的排放。我们的研究结果还突出显示了USCα在CH <sub> 4 </ sub>浓度升高的环境中的主要作用，并表明该组中的功能多样性比以前公认的更高。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726885[0m

Title: Diagnostic performances of the Afirma gene sequencing classifier in comparison with the gene expression classifier: A meta-analysis.

Journal: Cancer cytopathology (Cancer Cytopathol)

Date: 2020-Jul

Abstrct_EN: The Afirma microarray-based Gene Expression Classifier (GEC) with its high negative predictive value (NPV) and sensitivity has been used to rule out cancer from thyroid nodules with an indeterminate cytology but not to rule in cancer because of its low positive predictive value (PPV) and specificity. The Gene Sequencing Classifier (GSC) has been reported to improve on the weakness of GEC. In this study, a meta-analysis was performed to compare the clinical impact and diagnostic performance of GEC and GSC. Relevant data were searched in PubMed and Web of Science. Meta-analyses for proportion and dichotomous outcomes were performed to compare the benign call rates (BCRs), resection rates (RRs), risks of malignancy (ROMs), sensitivities, specificities, PPVs, and NPVs of GSC and GEC. Seven studies were included for the meta-analyses. Compared with GEC, GSC had a higher BCR (65.3% vs 43.8%; P < .001), a lower RR (26.8% vs 50.1%; P < .001), and a higher ROM (60.1% vs 37.6%; P < .001). The BCR of Hürthle cell-predominant nodules was significantly elevated (73.7% vs 21.4%; P < .001). In addition, the specificity (43.0% vs 25.1%; P = .003) and PPV (63.1% vs 41.6%; P = .004) of Afirma GSC were significantly improved while it still maintained a high sensitivity (94.3%) and a high NPV (90.0%). In conclusion, this study confirms and highlighted the clinical and diagnostic significance of GSC. With an increased BCR and improved diagnostic performance, GSC could reduce the rate of unnecessary surgical interventions and better tailor the clinical decisions of patients with indeterminate thyroid fine-needle aspiration results.

Abstrct_CN: 基于Afirma基因芯片的基因表达分类器（GEC）具有较高的阴性预测值（NPV）和敏感性，已被用于从细胞学不确定的甲状腺结节中排除癌症，但由于其阳性预测值较低，因此无法排除癌症（ PPV）和特异性。据报道，基因测序分类器（GSC）可改善GEC的弱点。在这项研究中，进行了荟萃分析，以比较GEC和GSC的临床影响和诊断性能。在PubMed和Web of Science中搜索了相关数据。进行了比例和二分结果的荟萃分析，以比较GSC和GEC的良性检出率（BCR），切除率（RR），恶性风险（ROM），敏感性，特异性，PPV和NPV。荟萃分析包括七项研究。与GEC相比，GSC的BCR较高（65.3％vs 43.8％; P <.001），RR较低（26.8％vs 50.1％; P <.001），ROM较高（60.1％vs 37.6％; P <.001）。 Hürthle细胞为主的结节的BCR显着升高（73.7％vs 21.4％; P <.001）。此外，Afirma GSC的特异性（43.0％vs 25.1％; P = .003）和PPV（63.1％vs 41.6％; P = .004）显着提高，同时仍保持高灵敏度（94.3％）和高净现值（90.0％）。总之，这项研究证实并强调了GSC的临床和诊断意义。随着BCR的增加和诊断性能的提高，GSC可以减少不必要的外科手术干预的比率，并更好地调整不确定的甲状腺细针穿刺结果患者的临床决策。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726822[0m

Title: Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future.

Journal: Hamostaseologie (Hamostaseologie)

Date: 2020-Aug

Abstrct_EN: A strong link between cancer and thrombosis has been well recognized. The occurrence of venous thromboembolism (VTE) can be the first clinical sign of an undiagnosed (i.e., occult) cancer. Cancer is more often diagnosed after unprovoked compared with provoked VTE events, with a reported risk in recent studies of around 5%. Extensive, imaging-based screening strategies to detect occult cancer after unprovoked VTE do not appear to have a clear clinical benefit compared with a more limited cancer screening. To identify patients with unprovoked VTE at high risk of occult cancer, risk factors have been explored and prediction models developed. Relevant risk factors for occult cancer include male sex, age, anemia, chronic lung disease, and thrombocytosis. Studies with preselection of patients based on risk assessment and evaluation of limited versus extensive screening strategies are currently ongoing. Also, novel and promising approaches for early detection of cancer in patients with unprovoked VTE by means of liquid biopsies, which include analysis of circulating tumor cells, cell-free tumor DNA, proteomics, or platelet mRNA sequencing, are currently under investigation. In this review, we provide an overview of the risk of cancer diagnosis after VTE, discuss the studies which investigated different screening strategies for occult cancer, summarize risk factors and risk scoring models for identification of patients at high risk of cancer diagnosis after VTE, and highlight ongoing research to optimize screening and identification of patients at risk of occult cancer, which will shape the future clinical practice.

Abstrct_CN: 癌症与血栓形成之间的紧密联系已得到公认。静脉血栓栓塞症（VTE）的发生可能是未诊断（即隐匿性）癌症的第一个临床体征。与激起的VTE事件相比，未经激怒后更容易诊断出癌症，据最近的研究报道，这一风险约为5％。与更有限的癌症筛查相比，基于影像学的广泛筛查策略在无缘无故的VTE后检测隐匿性癌症似乎没有明显的临床益处。为了确定具有隐匿性癌症高风险的未经证实的VTE患者，已经探索了危险因素并建立了预测模型。隐匿性癌症的相关危险因素包括男性，年龄，贫血，慢性肺病和血小板增多症。目前正在进行基于风险评估和有限筛查与广泛筛查策略评估的患者预选研究。另外，目前正在研究通过液体活检早期检测未经治疗的VTE患者的癌症的新颖且有希望的方法，包括分析循环肿瘤细胞，无细胞肿瘤DNA，蛋白质组学或血小板mRNA测序。在这篇综述中，我们概述了VTE后的癌症诊断风险，讨论了研究针对隐匿性癌症的不同筛查策略的研究，总结了风险因素和风险评分模型，以鉴定VTE后处于高癌症诊断风险的患者，以及重点介绍正在进行的研究，以优化对潜伏性癌症患者的筛查和鉴定，这将影响未来的临床实践。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726617[0m

Title: Cycling Stem Cells Are Radioresistant and Regenerate the Intestine.

Journal: Cell reports (Cell Rep)

Date: 2020-Jul

Abstrct_EN: A certain number of epithelial cells in intestinal crypts are DNA damage resistant and contribute to regeneration. However, the cellular mechanism underlying intestinal regeneration remains unclear. Using lineage tracing, we show that cells marked by an Msi1 reporter (Msi1<sup>+</sup>) are right above Lgr5<sup>high</sup> cells in intestinal crypts and exhibit DNA damage resistance. Single-cell RNA sequencing reveals that the Msi1<sup>+</sup> cells are heterogeneous with the majority being intestinal stem cells (ISCs). The DNA damage-resistant subpopulation of Msi1<sup>+</sup> cells is characterized by low-to-negative Lgr5 expression and is more rapidly cycling than Lgr5<sup>high</sup> radiosensitive crypt base columnar stem cells (CBCs). This enables an efficient repopulation of the intestinal epithelium at early stage when Lgr5<sup>high</sup> cells are not emerging. Furthermore, relative to CBCs, Msi1<sup>+</sup> cells preferentially produce Paneth cells during homeostasis and upon radiation repair. Together, we demonstrate that the DNA damage-resistant Msi1<sup>+</sup> cells are cycling ISCs that maintain and regenerate the intestinal epithelium.

Abstrct_CN: 肠隐窝中的一定数量的上皮细胞具有抗DNA损伤作用，并有助于再生。然而，肠再生的细胞机制仍不清楚。使用谱系追踪，我们发现由Msi1报告基因（Msi1 <sup> + </ sup>）标记的细胞在肠道隐窝中的Lgr5 <sup> high </ sup>细胞正上方，并且表现出对DNA的抵抗力。单细胞RNA测序显示Msi1 <sup> + </ sup>细胞是异质的，大多数是肠道干细胞（ISC）。 Msi1 <sup> + </ sup>细胞的耐DNA损伤亚群的特征是低至负Lgr5表达，并且比Lgr5 <sup>高</ sup>放射敏感性隐窝基础柱状干细胞（CBCs）循环更快）。当Lgr5 <sup> high </ sup>细胞没有出现时，这可以在早期阶段有效地补充肠道上皮。此外，相对于CBC，Msi1 <sup> + </ sup>细胞在稳态和放射修复后优先产生Paneth细胞。在一起，我们证明耐DNA损伤的Msi1 <sup> + </ sup>细胞是维持和再生肠上皮的循环ISC。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726445[0m

Title: Association between Vaginal Bacterial Microbiota and Vaginal Yeast Colonization.

Journal: The Journal of infectious diseases (J. Infect. Dis.)

Date: 2020-Jul

Abstrct_EN: Vaginal yeast is frequently found with Lactobacillus-dominant microbiota. The relationship between vaginal yeast and other bacteria has not been well characterized. These analyses utilized data from the Preventing Vaginal Infections trial. Relative abundance of vaginal bacteria from 16S rRNA gene amplicon sequencing and quantities of 10 vaginal bacteria using taxon-directed PCR assays were compared at visits with and without detection of yeast on microscopy, culture, or both. Higher relative abundances of Megasphaera species type 1 (RR 0.70, 95%CI 0.52-0.95), Megasphaera species type 2 (RR 0.81, 95%CI 0.67-0.98) and Mageeibacillus indolicus (RR 0.46, 95%CI 0.25-0.83), were associated with lower risk of detecting yeast. Conversely, higher relative abundances of Bifidobacterium bifidum, Aerococcus christensenii, Lactobacillus mucosae, Streptococcus equinus/infantarius/lutentiensis, Prevotella bivia, Dialister propionicifaciens, and Lactobacillus crispatus/helveticus were associated with yeast detection. Taxon-directed assays confirmed that increasing quantities of both Megasphaera species and M. indolicus were associated with lower risk of detecting yeast while, increasing quantities of L. crispatus were associated with higher risk of detecting yeast. Despite an analysis that examined associations between multiple vaginal bacteria and the presence of yeast, only a small number of vaginal bacteria were strongly and significantly associated with the presence or absence of yeast.

Abstrct_CN: 阴道酵母经常发现有以乳杆菌为主的菌群。阴道酵母菌与其他细菌之间的关系尚未得到很好的表征。这些分析利用了预防阴道感染试验的数据。在进行显微镜检查和/或在显微镜下检测或未检测到酵母的情况下，在访问和不进行酵母检测的情况下，对来自16S rRNA基因扩增子测序的阴道细菌的相对丰度和使用分类群定向PCR检测的10种阴道细菌的数量进行了比较。 1型大球藻（RR 0.70，95％CI 0.52-0.95），2型大球藻（RR 0.81，95％CI 0.67-0.98）和靛蓝杆菌（Mageeibacillus indolicus）（RR 0.46，95％CI 0.25-0.83）的相对丰度较高，被发现酵母的风险较低。相反，双歧双歧杆菌，克里斯滕森气单球菌，粘膜乳杆菌，马链球菌/ infantarius / lutentiensis，Bivo丙酸杆菌，Dialister丙酸杆菌和crispisteruscrispatus / helveticus的相对丰度与酵母检测相关。以分类群为导向的测定法证实，麦加氏球菌和靛蓝念珠菌数量的增加与检测酵母菌的风险较低有关，而松香乳酸菌的增加与检测酵母菌的风险较高有关。尽管有一项分析检查了多种阴道细菌与酵母菌之间的关联，但只有少数阴道细菌与酵母菌的存在与否密切相关。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726432[0m

Title: Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.

Journal: Journal of the National Cancer Institute (J. Natl. Cancer Inst.)

Date: 2020-Jul

Abstrct_EN: Radiation therapy is one of the most commonly used cancer therapeutics, but genetic determinants of clinical benefit are poorly characterized. Pathogenic germline variants in ATM are known to cause ataxia-telangiectasia, a rare hereditary syndrome notable for marked radiosensitivity. In contrast, somatic inactivation of ATM is a common event in a wide variety of cancers, but its clinical actionability remains obscure. We analyzed 20,107 consecutively treated advanced cancer patients who underwent targeted genomic sequencing as part of an institutional genomic profiling initiative and identified 1,085 harboring a somatic or germline ATM mutation, including 357 who received radiotherapy. Outcomes of irradiated tumors harboring ATM loss-of-function (LoF) mutations were compared to those harboring variants of unknown significance (VUS). All statistical tests were two-sided. Among 357 pan-cancer patients who received 727 courses of radiotherapy, genetic inactivation of ATM was associated with improved radiotherapeutic efficacy. The 2-year cumulative incidence of irradiated tumor progression was 13.2% vs 27.5% for tumors harboring an ATM LoF vs VUS allele, respectively (HR: 0.51, 95% CI = 0.34-0.77, p= .001). The greatest clinical benefit was seen in tumors harboring bi-allelic ATM inactivation (HR = 0.19, 95% CI = 0.06-0.60, p=.005), with statistically significant benefit also observed in tumors with mono-allelic ATM inactivation (HR = 0.57, 95% CI = 0.35-0.92, p=.02). Notably, ATM LoF was highly predictive of outcome in TP53 wild type tumors, but not among TP53-mutant tumors. We demonstrate that somatic ATM inactivation is associated with markedly improved tumor control following radiotherapy. The identification of a radiosensitive tumor phenotype across multiple cancer types offers potential clinical opportunities for genomically-guided radiotherapy.

Abstrct_CN: 放射疗法是最常用的癌症疗法之一，但是临床获益的遗传决定因素的特征却很差。已知ATM中的致病种系变异体会导致共济失调-毛细血管扩张，这是一种罕见的遗传综合征，以显着的放射敏感性为特征。相比之下，ATM的体细胞失活是多种癌症中的常见事件，但其临床可操作性仍然不清楚。我们分析了20107例经过连续治疗的晚期癌症患者，这些患者接受了针对性的基因组测序，这是机构性基因组分析计划的一部分，确定了1,085例具有体细胞或种系ATM突变的患者，其中357例接受了放射治疗。将携带ATM功能丧失（LoF）突变的放射肿瘤的结果与携带未知重要性变体（VUS）的结果进行比较。所有统计检验都是双面的。在接受727疗程放射治疗的357名全癌患者中，ATM的基因失活与放疗疗效提高相关。 2年累积的放疗肿瘤进展累积发生率分别为13.2％和27.5％，而分别携带ATM LoF和VUS等位基因的患者（HR：0.51，95％CI = 0.34-0.77，p = 0.001）。在具有双等位基因ATM失活的肿瘤中观察到最大的临床获益（HR = 0.19，95％CI = 0.06-0.60，p = .005），单等位基因ATM失活的肿瘤（HR = 0.57，95％CI ＝ 0.35-0.92，p ＝ 0.02）。值得注意的是，ATM LoF可以高度预测TP53野生型肿瘤的预后，但不能预测TP53突变型肿瘤的预后。我们证明了体细胞ATM失活与放疗后肿瘤控制明显改善有关。跨多种癌症类型的放射敏感性肿瘤表型的鉴定为基因组指导的放射治疗提供了潜在的临床机会。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32726325[0m

Title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.

Journal: PloS one (PLoS ONE)

Date: No article date

Abstrct_EN: Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection. In this work we searched for putative ACE2 and TMPRSS2 expression regulation networks mediated by various miRNA isoforms (isomiR) across different human organs using publicly available paired miRNA/mRNA-sequencing data from The Cancer Genome Atlas (TCGA) project. As a result, we identified several miRNA families targeting ACE2 and TMPRSS2 genes in multiple tissues. In particular, we found that lysine-specific demethylase 5B (JARID1B), encoded by the KDM5B gene, can indirectly affect ACE2 / TMPRSS2 expression by repressing transcription of hsa-let-7e / hsa-mir-125a and hsa-mir-141 / hsa-miR-200 miRNA families which are targeting these genes.

Abstrct_CN: 在正在进行的COVID-19大流行的背景下，调节血管紧张素转化酶2（ACE2）和跨膜丝氨酸蛋白酶2（TMPRSS2）表达的新方法的开发变得越来越重要，因为这些酶在细胞感染中起着至关重要的作用。在这项工作中，我们使用了来自癌症基因组图谱（TCGA）项目的公开配对的miRNA / mRNA测序数据，搜索了跨越不同人体器官的各种miRNA亚型（isomiR）介导的假定的ACE2和TMPRSS2表达调控网络。结果，我们在多个组织中鉴定了靶向ACE2和TMPRSS2基因的几个miRNA家族。特别是，我们发现由KDM5B基因编码的赖氨酸特异性脱甲基酶5B（JARID1B）可以通过抑制hsa-let-7e / hsa-mir-125a和hsa-mir-141 /的转录而间接影响ACE2 / TMPRSS2的表达。针对这些基因的hsa-miR-200 miRNA家族。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32725539[0m

Title: Retrospective Observational Study of ALK-Inhibitor Therapy Sequencing and Outcomes in Patients with ALK-Positive Non-small Cell Lung Cancer.

Journal: Drugs - real world outcomes (Drugs Real World Outcomes)

Date: 2020-Jul

Abstrct_EN: Data are sparse concerning the sequential use of multiple anaplastic lymphoma kinase (ALK) inhibitors for ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). This study investigated sequencing and outcomes among patients receiving multiple ALK inhibitors. This was a retrospective observational cohort study of adult patients with ALK-positive NSCLC treated with available first- and second-generation ALK inhibitors from 1 September 2011 to 31 December 2017. Duration of therapy (DOT) and overall survival (OS) were assessed with the Kaplan-Meier method. A multivariable linear regression analysis was performed to assess if DOT with a preceding ALK inhibitor was predictive of DOT for subsequent ALK inhibitor treatments. A total of 410 patients were analyzed: 57% received 1 ALK inhibitor; 35%, 2 ALK inhibitors; and 8%, 3-4 ALK inhibitors. Among those receiving > 1 ALK inhibitor (n = 177), 60% received a crizotinib-led sequence and 39% an alectinib-led sequence. Nearly 60% of the overall population received chemotherapy prior to their first ALK inhibitor. Median OS for the study population was 28 months, 15 months in patients who received 1 ALK inhibitor, 42 months in patients who received 2 ALK inhibitors, and 56 months in patients who received 3-4 ALK inhibitors. Longer DOT of the first ALK inhibitor was associated with increased DOT of the second (p < 0.0001), and longer DOT of the second ALK inhibitor was associated with increased DOT of the third (p < 0.0001). This study provides initial information on real-world treatment patterns following the introduction of new ALK inhibitors, and supports the use of sequential ALK therapies.

Abstrct_CN: 关于ALK阳性局部晚期或转移性非小细胞肺癌（NSCLC）连续使用多种间变性淋巴瘤激酶（ALK）抑制剂的数据很少。这项研究调查了接受多种ALK抑制剂的患者的测序和预后。这是一项回顾性队列研究，研究对象为2011年9月1日至2017年12月31日接受第一代和第二代ALK抑制剂治疗的ALK阳性NSCLC成年患者。采用以下方法评估治疗时间（DOT）和总生存期（OS）： Kaplan-Meier方法。进行了多变量线性回归分析，以评估使用先前ALK抑制剂的DOT是否可预测随后ALK抑制剂治疗的DOT。总共对410位患者进行了分析：57％的患者接受了1种ALK抑制剂； 35％，2种ALK抑制剂;和8％的3-4种ALK抑制剂。在那些接受＞＞ 1个ALK抑制剂的患者中（n ＝＝ 177），60％接受了克唑替尼引导的序列，而39％接受了依爱替尼引导的序列。将近60％的总人口在使用第一种ALK抑制剂之前接受了化疗。研究人群的OS中位数为28个月，接受1种ALK抑制剂的患者为15个月，接受2种ALK抑制剂的患者为42个月，接受3-4种ALK抑制剂的患者为56个月。第一种ALK抑制剂的较长DOT与第二种ALK抑制剂的DOT增加有关（p <0.0001），第二种ALK抑制剂的较长DOT与第三种ALK抑制剂的DOT增加有关（p <0.00010001）。引入新的ALK抑制剂后，这项研究提供了有关现实世界治疗模式的初步信息，并支持顺序性ALK疗法的使用。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32725451[0m

Title: Effects of high-intensity interval training on gut microbiota profiles in 12 months' old ICR mice.

Journal: Journal of physiology and biochemistry (J. Physiol. Biochem.)

Date: 2020-Jul

Abstrct_EN: High-intensity interval training (HIT) has been proposed to exert multiple beneficial effects and positively affect gut microbiota, while how HIT would affect gut microbiota profiles in middle-aged mice remain unreported. Male ICR mice (12 months old) were divided into two groups, i.e., control group (CON) and HIT exercise group (HIT) given HIT running with a total of 7 weeks. Fecal content from the gut was collected eventually and gut microbiota were determined via 16S rRNA gene sequencing. Compared with CON group, mice from HIT group exhibited improved gut microbial diversity including increased Shannon index. Compared with the CON group, at the phylum level, the relative abundance of Proteobacteria and TM7 was significantly decreased and increased, respectively, from HIT group. At the genera level, HIT group had significantly increased Dorea and Dehalobacterium, while decreased Candidatus Arthromitus. PICRUSt analysis at level 2 and level 3 of KEGG pathways demonstrated that the cecal microbiota of mice from HIT group had significantly enriched pathways involved in carbohydrate metabolism, signal transduction mechanisms, and transcription, while reduced pathways involved in renal cell carcinoma, Huntington's disease, pathways in cancer, various types of N-glycan biosynthesis, Alzheimer's disease, glycan biosynthesis and metabolism, lipopolysaccharide biosynthesis, cell motility and secretion, and lipopolysaccharide biosynthesis proteins. In conclusion, HIT could dynamically alter gut microbiota profiles in middle-aged mice. How altered gut microbiota profiles could affect the biological functions of HIT need to be further explored.

Abstrct_CN: 已提出高强度间歇训练（HIT）发挥多种有益作用并积极影响肠道菌群，而HIT将如何影响中年小鼠的肠道菌群特征仍未报道。将雄性ICR小鼠（12个月大）分为两组，即对照组（CON）和HIT运动组（HIT）进行HIT跑步，总共进行7周。最终从肠道收集粪便含量，并通过16S rRNA基因测序确定肠道菌群。与CON组相比，HIT组小鼠表现出改善的肠道微生物多样性，包括增加的Shannon指数。与CON组相比，HIT组在门水平上，Proteobacteria和TM7的相对丰度分别显着降低和升高。在属水平上，HIT组的Dorea和Dehalobacterium明显增加，而Artandomitus假丝酵母则减少。 KEGG途径第2级和第3级的PICRUSt分析表明，HIT组小鼠的盲肠菌群具有丰富的参与碳水化合物代谢，信号转导机制和转录的途径，而减少了涉及肾细胞癌，亨廷顿舞蹈病的途径在癌症中，各种类型的N-聚糖生物合成，阿尔茨海默氏病，聚糖生物合成和代谢，脂多糖生物合成，细胞运动和分泌以及脂多糖生物合成蛋白。总之，HIT可以动态改变中年小鼠的肠道菌群特征。肠道微生物群的变化如何影响HIT的生物学功能有待进一步探讨。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32725165[0m

Title: In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.

Journal: Bioscience reports (Biosci. Rep.)

Date: 2020-Jul

Abstrct_EN: Glioma is the common histological subtype of malignancy in central nervous system, with a high morbidity and mortality. Cancer stem cells (CSCs) play an important role in regulating the tumorigenesis and progression of glioma, however, the prognostic biomarkers and therapeutic targets associated with CSC characteristics have not been fully acknowledged in glioma. In order to identify the prognostic stemness-related genes (SRGs) of glioma in silico, the RNA sequencing data of patients with glioma were retrieved from The Cancer Genome Atlas (TCGA) databases. The mRNA expression-based stemness index (mRNAsi) was significantly associated with the glioma histologic grade, isocitrate dehydrogenase 1 (IDH1) mutation and overall survival of glioma patients by the nonparametric test and Kaplan-Meier survival analysis. A total of 340 SRGs were identified as the overlapped stemness-related differential expressed genes (DEGs) of different histologic grade screened by the univariate Cox analysis. Based on 11 prognostic SRGs, the predict nomogram was constructed with the AUC of 0.832. Moreover, the risk score of the nomogram was an independent prognostic factor, indicating its significant applicability. Besides other 8 reported biomarkers of glioma, we found that F2RL2, CLCNKA and LOXL4 were firstly identified as prognostic biomarkers for glioma. In conclusion, this bioinformatics study demonstrates the mRNAsi as a reliable index for the IDH1 mutation, histologic grade and OS of glioma patients andprovides a well-applied model for predicting the OS for patients with glioma based on prognostic SRGs. Additionally, this in silico study also identifies three novel prognostic biomarkers (F2RL2, CLCNKA and LOXL4) for glioma patients.

Abstrct_CN: 胶质瘤是中枢神经系统恶性肿瘤的常见组织学亚型，发病率和死亡率高。癌症干细胞（CSC）在调节神经胶质瘤的发生和发展中起着重要作用，但是，与CSC特征相关的预后生物标志物和治疗靶标在神经胶质瘤中尚未得到充分认识。为了鉴定神经胶质瘤的预后干性相关基因（SRG），从癌症基因组图谱（TCGA）数据库中检索了神经胶质瘤患者的RNA测序数据。通过非参数测试和Kaplan-Meier生存分析，基于mRNA表达的干度指数（mRNAsi）与神经胶质瘤的组织学等级，异柠檬酸脱氢酶1（IDH1）突变和神经胶质瘤患者的总体生存率显着相关。通过单变量Cox分析筛选出总共340个SRG，它们是不同组织学等级的重叠干性相关差异表达基因（DEG）。基于11个预后的SRG，以0.832的AUC构建预测列线图。此外，列线图的风险评分是独立的预后因素，表明其显着的适用性。除了报告的其他8种神经胶质瘤生物标志物外，我们还发现F2RL2，CLCNKA和LOXL4首先被鉴定为神经胶质瘤的预后生物标志物。总之，这项生物信息学研究表明，mRNAsi可作为胶质瘤患者IDH1突变，组织学等级和OS的可靠指标，并提供了一种基于预后性SRGs预测胶质瘤患者OS的良好模型。此外，这项计算机模拟研究还为神经胶质瘤患者确定了三种新的预后生物标志物（F2RL2，CLCNKA和LOXL4）。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724874[0m

Title: Genetic analysis in the clinical management of biliary tract cancer.

Journal: Annals of gastroenterological surgery (Ann Gastroenterol Surg)

Date: 2020-Jul

Abstrct_EN: Biliary tract cancer (BTC) is clinically and pathologically heterogeneous and responds inadequately to treatment. A small section of patients develop resectable disease, although the relapse rates are high; the benefits of adjuvant capecitabine chemotherapy for BTC are now understood, and gemcitabine-based combination chemotherapy is the first line of therapeutic strategy for BTC; however, alternative therapy for BTC is not known. Genomic profiling can provide detailed information regarding the carcinogenesis, identification, and therapy for BTC. Currently, confirmed restorative targets for BTC are lacking. In this review, we aimed to analyze the preclinical and clinical implications of a spectrum of genomic alterations associated with new potentially remedial targets. We focused on eight draggable genes for BTC, which were described as having evidence of therapeutic impact (evidence level 2A-3B) based on the clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment; these include ERBB2, NTRK1, RNF43, CDK6, CDKN2B, FGFR2, IDH1, and IDH2. Moreover, some of the BTC present microsatellite instability, hypermutation, and germline variants, which we also reviewed. Finally, we discussed the therapeutic options based on the next-generation sequencing findings in BTC. Studies have demonstrated that BTC includes subgroups with individually distinct driver mutations, most of which will be targeted with new treatment plans.

Abstrct_CN: 胆道癌（BTC）在临床和病理上是异质性的，对治疗的反应不足。尽管复发率很高，但是一小部分患者会发展为可切除的疾病。现在已经了解了卡培他滨辅助化疗对BTC的益处，基于吉西他滨的联合化疗是BTC治疗策略的第一线；但是，BTC的替代疗法尚不清楚。基因组概况分析可以提供有关BTC的致癌性，鉴定和治疗的详细信息。目前，缺乏确定的BTC恢复目标。在这篇综述中，我们旨在分析与新的潜在治疗靶标相关的一系列基因组改变的临床前和临床意义。我们集中研究了BTC的八个可拖动基因，这些基因被描述为具有治疗效果的证据（证据水平2A-3B），基于下一代测序在癌症诊断和治疗中的临床实践指南。这些包括ERBB2，NTRK1，RNF43，CDK6，CDKN2B，FGFR2，IDH1和IDH2。此外，一些BTC存在微卫星不稳定性，超突变和种系变异，我们也对此进行了回顾。最后，我们讨论了基于BTC中下一代测序发现的治疗选择。研究表明，BTC包括具有各自不同的驱动程序突变的亚组，其中大多数将针对新的治疗计划。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724790[0m

Title: Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer.

Journal: International journal of genomics (Int J Genomics)

Date: No article date

Abstrct_EN: Breast cancer development and progression involve both germline and somatic mutations. High-throughput genotyping and next-generation sequencing technologies have enabled discovery of genetic risk variants and acquired somatic mutations driving the disease. However, the possible oncogenic interactions between germline genetic risk variants and somatic mutations in triple-negative breast cancer (TNBC) and non-triple-negative breast cancer (non-TNBC) have not been characterized. Here, we delineated the possible oncogenic interactions between genes containing germline and somatic mutations in TNBC and non-TNBC and investigated whether there are differences in gene expression and mutation burden between the two types of breast cancer. We addressed this problem by integrating germline mutation information from genome-wide association studies with somatic mutation information from next-generation sequencing using gene expression data as the intermediated phenotype. We performed network and pathway analyses to discover molecular networks and signalling pathways enriched for germline and somatic mutations. The investigation revealed signatures of differentially expressed and differentially somatic mutated genes between TNBC and non-TNBC. Network and pathway analyses revealed functionally related genes interacting in gene regulatory networks and multiple signalling pathways enriched for germline and somatic mutations for each type of breast cancer. Among the signalling pathways discovered included the DNA repair and Androgen and ATM signalling pathways for TNBC and the DNA damage response, molecular mechanisms of cancer, and ATM and GP6 signalling pathways for non-TNBC. The results show that integrative genomics is a powerful approach for delineating oncogenic interactions between genes containing germline and genes containing somatic mutations in TNBC and non-TNBC and establishes putative functional bridges between genetic and somatic alterations and the pathways they control in the two types of breast cancer.

Abstrct_CN: 乳腺癌的发生和发展涉及种系和体细胞突变。高通量基因分型和下一代测序技术使人们能够发现遗传风险变异和驱动该疾病的获得性体细胞突变。然而，尚未鉴定出三阴性乳腺癌（TNBC）和非三阴性乳腺癌（non-TNBC）的种系遗传风险变异与体细胞突变之间可能的致癌相互作用。在这里，我们描述了TNBC和非TNBC中包含种系和体细胞突变的基因之间可能的致癌相互作用，并研究了两种乳腺癌之间在基因表达和突变负担方面是否存在差异。我们通过使用基因表达数据作为中间表型，整合了来自全基因组关联研究的种系突变信息与来自下一代测序的体细胞突变信息，从而解决了这个问题。我们进行了网络和途径分析，以发现丰富了种系和体细胞突变的分子网络和信号传导途径。调查显示了TNBC和非TNBC之间差异表达和差异体细胞突变基因的特征。网络和途径分析揭示了与功能相关的基因在基因调控网络中相互作用，并且为多种类型的乳腺癌的种系和体细胞突变丰富了多种信号传导途径。发现的信号传导途径包括TNBC的DNA修复，雄激素和ATM信号传导途径以及DNA损伤反应，癌症的分子机制以及非TNBC的ATM和GP6信号传导途径。结果表明，整合基因组学是描述TNBC和非TNBC中包含种系的基因与包含体细胞突变的基因之间的致癌相互作用的有效方法，并建立了遗传和体细胞变化之间的推定功能桥梁，以及它们在两种类型的乳腺中控制的途径癌症。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724459[0m

Title: Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.

Journal: Theranostics (Theranostics)

Date: No article date

Abstrct_EN: <b>Background:</b> Triple-negative breast cancer (TNBC) is one of the most prevalent neoplastic diseases worldwide, but efficacious treatments for this pathological condition are still challenging. The lack of an effective targeted therapy also leads to a poor prognosis for patients affected by TNBC. In the present study, we repurposed the distinctive inhibitory effects of flubendazole, a traditional anthelmintic drug, towards the putative modulation of proliferation and migration of TNBC <i>in vitro and in vivo</i>. <b>Methods:</b> According to a series of experimental approaches, including immunofluorescence (IF), immunoblotting (IB), siRNA and GFP-mRFP-LC3 plasmid transfection, respectively, we have found that flubendazole is capable of inducing autophagic cell death and apoptosis, thus exerting some anti-proliferative and anti-migration activity in TNBC cells. The therapeutic effects of flubendazole were evaluated by xenograft mouse models, followed by immunohistochemistry (IHC), IF and IB. Changes in the gene expression profiles of flubendazole-treated TNBC cells were analyzed by RNA sequencing (RNA-seq) and validated by IB. The potential binding mode of flubendazole and EVA1A was predicted by molecular docking and demonstrated by site-directed mutagenesis. <b>Results:</b> We have presently found that flubendazole exhibits a considerable anti-proliferative activity <i>in vitro</i> and <i>in vivo</i>. Mechanistically, the induction of autophagic cell death appears to be pivotal for flubendazole-mediated growth inhibition of TNBC cells, whereas blocking autophagy was able to improve the survival rate and migration ability of flubendazole-treated TNBC cells. Specifically, RNA-seq analysis showed that flubendazole treatment could promote the up-regulation of EVA1A. Flubendazole may regulate autophagy and apoptosis by targeting EVA1A, thus affecting the mechanisms of TNBC proliferation and migration. Furthermore, Thr113 may be the key amino acid residues for the binding of flubendazole to EVA1A. <b>Conclusion:</b> Our results provide novel insights towards the putative anti-cancer efficacy of flubendazole. Furthermore, here we show that flubendazole could serve as a potential therapeutic drug in TNBC. Altogether, this study highlights the possibility of this repurposed autophagic inducer for future cancer treatments.

Abstrct_CN: <b>背景：</ b>三阴性乳腺癌（TNBC）是世界上最普遍的赘生性疾病之一，但是对于这种病理状况的有效治疗仍然具有挑战性。缺乏有效的靶向治疗还导致受TNBC影响的患者预后较差。在本研究中，我们将氟苯达唑（一种传统的驱虫药）的独特抑制作用重新定位于推测的TNBC在体外和体内的增殖和迁移调节。 <b>方法：</ b>根据一系列实验方法，包括免疫荧光（IF），免疫印迹（IB），siRNA和GFP-mRFP-LC3质粒转染，我们发现flubendazole能够诱导自噬。细胞死亡和凋亡，从而在TNBC细胞中发挥一些抗增殖和抗迁移活性。通过异种移植小鼠模型，随后免疫组织化学（IHC），IF和IB评估了氟苯达唑的治疗效果。氟苯达唑处理的TNBC细胞基因表达谱的变化通过RNA测序（RNA-seq）分析并通过IB验证。氟苯达唑和EVA1A的潜在结合模式通过分子对接预测，并通过定点诱变证明。 <b>结果：</ b>我们目前发现，氟苯达唑<i>在体外</ i>和在体内<i>具有相当大的抗增殖活性。从机制上讲，自噬细胞死亡的诱导似乎是由flubendazole介导的TNBC细胞生长抑制的关键，而阻断自噬则能够提高flubendazole处理的TNBC细胞的存活率和迁移能力。具体来说，RNA-seq分析表明，氟苯达唑处理可以促进EVA1A的上调。氟苯达唑可通过靶向EVA1A调节自噬和凋亡，从而影响TNBC增殖和迁移的机制。此外，Thr113可能是氟苯达唑与EVA1A结合的关键氨基酸残基。 <b>结论：</ b>我们的结果为氟苯达唑的假定抗癌功效提供了新颖的见解。此外，在这里我们显示了氟苯达唑可以作为TNBC中潜在的治疗药物。总而言之，这项研究突出了这种重新定位的自噬诱导剂用于未来癌症治疗的可能性。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724444[0m

Title: A robust method for the rapid detection of microsatellite instability in colorectal cancer.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: Although several computational tools using next-generation sequencing (NGS) data have been proposed to detect microsatellite instability (MSI) status, they still have limitations and need improvement. We developed a NovoPM-MSI method to detect MSI status based on NGS data. This method evaluated target mononucleotide microsatellite loci that were sequenced during targeted gene enrichment analysis and reported sample instability score as the fraction of unstable loci within the target set after assessing locus instability by comparing length distribution in paired tumor-normal samples. We validated this method against the conventional MSI-PCR method in 113 paired colorectal cancer (CRC) specimens and compared the performance of NovoPM-MSI to that of mSINGS and MANTIS in accuracy and runtime efficiency. By using the MSI status from MSI-PCR as the gold standard, the three computational methods showed the same sensitivity of 88.9% but different specificities (NovoPM-MSI 97.1%, MANTIS 86.5% and mSINGS 99.0%). Only NovoPM-MSI could greatly improve both the sensitivity and specificity by setting an ambiguous interval. MANTIS had the shortest average runtime (16.3 sec), followed by NovoPM-MSI (18.3 sec) and mSINGS (109.0 sec). In short, the NovoPM-MSI method provides a fast and reliable MSI detection method with accuracy comparable to MSI-PCR in paired CRC samples.

Abstrct_CN: 尽管已经提出了几种使用下一代测序（NGS）数据的计算工具来检测微卫星不稳定性（MSI）状态，但它们仍然有局限性，需要改进。我们开发了一种NovoPM-MSI方法，用于根据NGS数据检测MSI状态。该方法评估了在靶基因富集分析过程中测序的靶单核苷酸微卫星基因座，并通过比较配对的正常肿瘤样本中的长度分布来评估基因座不稳定性后，将样本不稳定性分数报告为目标集中不稳定基因座的分数。我们在113个配对的结直肠癌（CRC）标本中针对传统MSI-PCR方法验证了该方法，并比较了NovoPM-MSI与mSINGS和MANTIS在准确性和运行效率方面的性能。通过使用MSI-PCR的MSI状态作为金标准，这三种计算方法显示出相同的灵敏度88.9％，但特异性不同（NovoPM-MSI 97.1％，MANTIS 86.5％和mSINGS 99.0％）。通过设置不明确的间隔，只有NovoPM-MSI才能大大提高敏感性和特异性。 MANTIS的平均运行时间最短（16.3秒），其次是NovoPM-MSI（18.3秒）和mSINGS（109.0秒）。简而言之，NovoPM-MSI方法提供了一种快速可靠的MSI检测方法，其准确性可与配对CRC样本中的MSI-PCR媲美。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724428[0m

Title: Long non-coding RNA EWSAT1 contributes to the proliferation and invasion of glioma by sponging miR-152-3p.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: Long non-coding RNAs (lncRNA) are a type of ncRNA with a length ranging from 200-1,000 nucleotides. Previous studies have confirmed that the lncRNA Ewing sarcoma associated transcript 1 (EWSAT1) exerts regulatory roles in cancer development and progression. However, its clinical significance in glioma remains unknown. In the present study, RNA-sequencing data from the Gene Expression Omnibus database and The Cancer Genome Atlas was explored to investigate the association between EWSAT1 expression and prognosis in patients with glioma. Increased EWSAT1 was associated with the presence of necrosis on magnetic resonance imaging scans in patients with glioma. Furthermore, knockdown of EWSAT1 was indicated to suppress the proliferative and invasive abilities of glioblastoma cell lines using Cell Counting Kit-8 and Transwell assays. Additionally, microRNA (miR)-152-3p was identified as a potential target of EWSAT1. The present study demonstrated that EWSAT1 interacted directly with miR-152-3p, and rescue experiments confirmed that EWSAT1 participated in glioma development by suppressing miR-152-3p. These results indicated that EWSAT1 is involved in the occurrence and progression of glioma, and may serve as a novel target and potential prognostic biomarker of glioma treatment.

Abstrct_CN: 长非编码RNA（lncRNA）是一种ncRNA，长度范围为200-1,000个核苷酸。先前的研究已经证实，lncRNA尤因肉瘤相关转录本1（EWSAT1）在癌症的发展和进程中发挥调节作用。然而，其在神经胶质瘤中的临床意义仍然未知。在本研究中，探索了来自Gene Expression Omnibus数据库和The Cancer Genome Atlas的RNA测序数据，以研究EWSAT1表达与神经胶质瘤患者预后之间的关系。胶质瘤患者的磁共振成像扫描显示，EWSAT1升高与坏死有关。此外，使用细胞计数试剂盒8（Cell Counting Kit-8）和Transwell分析表明，敲低EWSAT1可以抑制胶质母细胞瘤细胞系的增殖和侵袭能力。此外，microRNA（miR）-152-3p被确定为EWSAT1的潜在目标。本研究表明EWSAT1与miR-152-3p直接相互作用，救援实验证实EWSAT1通过抑制miR-152-3p参与了神经胶质瘤的发展。这些结果表明EWSAT1参与胶质瘤的发生和发展，并可能作为胶质瘤治疗的新目标和潜在的生物标志物。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724412[0m

Title: Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: Hepatocellular carcinoma (HCC) is a heterogeneous malignancy, which is a major cause of cancer morbidity and mortality worldwide. Thus, the aim of the present study was to identify the hub genes and underlying pathways of HCC via bioinformatics analyses. The present study screened three datasets, including GSE112790, GSE84402 and GSE74656 from the Gene Expression Omnibus (GEO) database, and downloaded the RNA-sequencing of HCC from The Cancer Genome Atlas (TCGA) database. The differentially expressed genes (DEGs) in both the GEO and TCGA datasets were filtered, and the screened DEGs were subsequently analyzed for functional enrichment pathways. A protein-protein interaction (PPI) network was constructed, and hub genes were further screened to create the Kaplan-Meier curve using cBioPortal. The expression levels of hub genes were then validated in different datasets using the Oncomine database. In addition, associations between expression and tumor grade, hepatitis virus infection status, satellites and vascular invasion were assessed. A total of 126 DEGs were identified, containing 70 upregulated genes and 56 downregulated genes from the GEO and TCGA databases. By constructing the PPI network, the present study identified hub genes, including cyclin B1 (CCNB1), cell-division cycle protein 20 (CDC20), cyclin-dependent kinase 1, BUB1 mitotic checkpoint serine/threonine kinase β (BUB1B), cyclin A2, nucleolar and spindle associated protein 1, ubiquitin-conjugating enzyme E2 C (UBE2C) and ZW10 interactor. Furthermore, upregulated CCNB1, CDC20, BUB1B and UBE2C expression levels indicated worse disease-free and overall survival. Moreover, a meta-analysis of tumor and healthy tissues in the Oncomine database demonstrated that BUB1B and UBE2C were highly expressed in HCC. The present study also analyzed the data of HCC in TCGA database using univariate and multivariate Cox analyses, and demonstrated that BUB1B and UBE2C may be used as independent prognostic factors. In conclusion, the present study identified several genes and the signaling pathways that were associated with tumorigenesis using bioinformatics analyses, which could be potential targets for the diagnosis and treatment of HCC.

Abstrct_CN: 肝细胞癌（HCC）是一种异质性恶性肿瘤，是全世界癌症发病率和死亡率的主要原因。因此，本研究的目的是通过生物信息学分析鉴定HCC的中心基因和潜在途径。本研究从Gene Expression Omnibus（GEO）数据库中筛选了三个数据集，包括GSE112790，GSE84402和GSE74656，并从The Cancer Genome Atlas（TCGA）数据库下载了HCC的RNA序列。过滤了GEO和TCGA数据集中的差异表达基因（DEG），随后分析了筛选的DEG的功能富集途径。构建了蛋白质-蛋白质相互作用（PPI）网络，并使用cBioPortal进一步筛选了枢纽基因以创建Kaplan-Meier曲线。然后使用Oncomine数据库在不同的数据集中验证轮毂基因的表达水平。此外，评估了表达与肿瘤等级，肝炎病毒感染状况，卫星和血管浸润之间的关联。总共鉴定出126个DEG，其中包含来自GEO和TCGA数据库的70个上调基因和56个下调基因。通过构建PPI网络，本研究确定了集线器基因，包括细胞周期蛋白B1（CCNB1），细胞分裂周期蛋白20（CDC20），细胞周期蛋白依赖性激酶1，BUB1有丝分裂检查点丝氨酸/苏氨酸激酶β（BUB1B），细胞周期蛋白A2 ，核仁和纺锤体相关蛋白1，泛素结合酶E2 C（UBE2C）和ZW10相互作用子。此外，CCNB1，CDC20，BUB1B和UBE2C表达水平上调表明无病和总体生存状况较差。此外，在Oncomine数据库中对肿瘤和健康组织的荟萃分析表明，BUB1B和UBE2C在HCC中高度表达。本研究还使用单变量和多变量Cox分析对TCGA数据库中的HCC数据进行了分析，并证明BUB1B和UBE2C可以用作独立的预后因素。总之，本研究使用生物信息学分析鉴定了几种与肿瘤发生有关的基因和信号通路，这可能是诊断和治疗HCC的潜在目标。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724403[0m

Title: Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: Glioblastoma (GBM) is the most aggressive and lethal tumor of the central nervous system. The present study set out to identify reliable prognostic and predictive biomarkers for patients with GBM. RNA-sequencing data were obtained from The Cancer Genome Atlas database and DNA methylation data were downloaded using the University of California Santa Cruz-Xena database. The expression and methylation differences between patients with GBM, and survival times <1 and ≥1 year were investigated. A protein-protein interaction network was constructed and functional enrichment analyses of differentially expressed and methylated genes were performed. Hub genes were identified using the Cytoscape plug-in cytoHubba software. Survival analysis was performed using the survminer package, in order to determine the prognostic values of the hub genes. The present study identified 71 genes that were hypomethylated and expressed at high levels, and four genes that were hypermethylated and expressed at low levels in GBM. These genes were predominantly enriched in the 'JAK-STAT signaling pathway', 'transcriptional misregulation in cancer' and the 'ECM-receptor interaction', which are associated with GBM development. Among the 24 hub genes identified, 15 possessed potential prognostic value. An integrative analysis approach was implemented in order to analyze the association of DNA methylation with changes in gene expression and to assess the association of gene expression changes with GBM survival time. The results of the present study suggest that these 15 CpG-based genes may be useful and practical tools in predicting the prognosis of patients with GBM. However, future research on gene methylation and/or expression is required in order to develop personalized treatments for patients with GBM.

Abstrct_CN: 胶质母细胞瘤（GBM）是中枢神经系统中最具攻击性和致死性的肿瘤。本研究着手确定GBM患者可靠的预后和预测性生物标志物。 RNA测序数据从The Cancer Genome Atlas数据库获得，DNA甲基化数据使用加利福尼亚大学圣克鲁斯分校数据库下载。研究GBM患者之间的表达和甲基化差异，以及生存时间<1年和≥1年。构建了蛋白质-蛋白质相互作用网络，并进行了差异表达和甲基化基因的功能富集分析。使用Cytoscape插件cytoHubba软件识别集线器基因。使用survminer软件包进行生存分析，以确定轮毂基因的预后价值。本研究在GBM中鉴定了71个低甲基化并高水平表达的基因，以及4个高甲基化并低水平表达的基因。这些基因主要富含与GBM发育相关的“ JAK-STAT信号传导途径”，“癌症转录失调”和“ ECM-受体相互作用”。在确定的24个中心基因中，有15个具有潜在的预后价值。为了分析DNA甲基化与基因表达变化之间的关系，并评估基因表达变化与GBM生存时间的关系，实施了一种综合分析方法。本研究的结果表明，这15个基于CpG的基因可能是预测GBM患者预后的有用和实用工具。然而，为了开发针对GBM患者的个性化治疗，需要对基因甲基化和/或表达进行进一步的研究。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724397[0m

Title: RNAseq profiling of circRNA expression in radiation-treated A549 cells and bioinformatics analysis of radiation-related circRNA-miRNA networks.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: With the development of new biochemical and computational methods, circular RNAs (circRNAs) have been identified as microRNA sponges. circRNAs are associated with many diseases, particularly cancer. The present study aimed to investigate the expression profile of circRNAs in irradiated A549 lung cancer cells using high-throughput sequencing. Bioinformatics analyses were used to examine the potential functions of circRNAs. RNA sequencing data demonstrated that 1,875 circRNA targets were differentially expressed in A549 cells in response to irradiation. A total of 30 circRNAs were upregulated and 37 circRNAs were downregulated significantly in irradiation-treated A549 cells (fold change ≥2.0; P<0.05). The top 5 upregulated and downregulated circRNAs were successfully validated by reverse transcription-quantitative PCR. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis suggested that differentially expressed circRNAs might be pivotal in biological irradiation responses to irradiation. circRNA-microRNA co-expression networks highlighted the biological significance of circRNA_0002174 and circRNA_0036627, which require further study. In conclusion, the present study is, to the best of the authors' knowledge, the first to describe the differentially expressed profile of circRNAs in response to irradiation in A549 cells. These results provide a new perspective to elucidate insight into the molecular mechanisms by which A549 cells respond to radiation, and a basis for a more in-depth analysis of the potential application of circRNAs in the treatment of lung cancer therapy.

Abstrct_CN: 随着新的生化和计算方法的发展，环形RNA（circRNA）已被鉴定为microRNA海绵。 circRNA与许多疾病，特别是癌症有关。本研究旨在使用高通量测序研究circRNA在照射的A549肺癌细胞中的表达情况。生物信息学分析用于检查circRNA的潜在功能。 RNA测序数据表明，响应辐射，A549细胞中有1,875个circRNA靶标差异表达。在经辐射处理的A549细胞中，总共有30个circRNA上调，而37个circRNA显着下调（倍数变化≥2.0； P <0.05）。通过逆转录定量PCR成功验证了前5个上调和下调的circRNA。此外，基因本体论（GO）和《京都基因与基因组百科全书》（KEGG）途径分析表明，差异表达的circRNA可能在生物辐射对辐射的反应中起关键作用。 circRNA-microRNA共表达网络突显了circRNA_0002174和circRNA_0036627的生物学意义，需要进一步研究。总之，据作者所知，本研究是第一个描述circRNAs在A549细胞中对放射反应的差异表达谱的研究。这些结果为阐明A549细胞对放射反应的分子机制提供了新的见解，并为更深入地分析circRNA在肺癌治疗中的潜在应用奠定了基础。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724395[0m

Title: Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: The immune checkpoint molecule B7 family member H4 (B7-H4) plays a similar role to programmed death-ligand 1 in tumor immune evasion by regulating T-cell-mediated immune responses. However, besides the role in T-cell immunity, B7-H4 also affects tumor cell biology by promoting tumor cell proliferation, metastasis and angiogenesis. In order to explore the effect of B7-H4 on tumor cell biology, it is necessary to investigate the gene expression profile when B7-H4 is overexpressed. In the present study, 786-O cells were transfected to stably express B7-H4. A microarray technique was subsequently used to screen B7-H4-related differentially expressed genes (DEGs) in B7-H4/786-O cells compared with negative control (NC)/786-O cells. The protein expression of the upregulated DEGs, including non-metastatic cells 5, NME/NM23 family member 5 (NME5), membrane metalloendopeptidase (MME), vascular non-inflammatory molecule 1 (VNN1), matrix metalloproteinase (MMP) 7, tumor necrosis factor, C-X-C motif chemokine ligand (CXCL) 8, CXCL1 and C-C motif chemokine ligand (CCL) 2, was investigated using western blotting. Kidney renal papillary cell carcinoma mRNA-sequencing data obtained from The Cancer Genome Atlas revealed that chemokines, including CXCL1/2/3, CXCL8, MMP7 and CCL20, were positively correlated with B7-H4 gene expression. Furthermore, 59 clinical renal cell carcinoma tissues were collected and analyzed by immunohistochemical staining. The results revealed the positive correlation of B7-H4 with CCL20 and CXCL8, and validated the DEGs identified in tumor cell lines. 786-O transfectants were inoculated into non-obese diabetic/severe combined immunodeficiency mice, and tumor growth was investigated. B7-H4 overexpression promoted tumor growth and administration of anti-CXCL8 antibody reversed this effect. Furthermore, B7-H4 overexpression increased the number of tumor-infiltrating neutrophils while inhibition of CXCL8 abrogated this effect. These data indicated that recruitment of neutrophils in the tumor microenvironment by CXCL8 serves an important role in the tumor promotion effect of B7-H4. The present study revealed a novel mechanism of B7-H4 in tumor promotion in addition to T cell inhibition.

Abstrct_CN: 免疫检查点分子B7家族成员H4（B7-H4）通过调节T细胞介导的免疫反应，在肿瘤免疫逃逸中与程序性死亡配体1发挥相似的作用。然而，除了在T细胞免疫中的作用外，B7-H4还通过促进肿瘤细胞增殖，转移和血管生成来影响肿瘤细胞生物学。为了探讨B7-H4对肿瘤细胞生物学的影响，有必要研究B7-H4过表达时的基因表达谱。在本研究中，转染了786-O细胞以稳定表达B7-H4。与阴性对照（NC）/ 786-O细胞相比，微阵列技术随后用于筛选B7-H4 / 786-O细胞中B7-H4相关的差异表达基因（DEG）。上调的DEGs的蛋白表达，包括非转移细胞5，NME / NM23家族成员5（NME5），膜金属内肽酶（MME），血管非炎性分子1（VNN1），基质金属蛋白酶（MMP）7，肿瘤坏死使用蛋白质印迹法研究了CXC基序趋化因子配体（CXCL）8，CXCL1和CC基序趋化因子配体（CCL）2这一因子。从癌症基因组图谱获得的肾脏肾乳头状细胞癌mRNA测序数据显示，包括CXCL1 / 2/3，CXCL8，MMP7和CCL20在内的趋化因子与B7-H4基因表达正相关。此外，收集了59个临床肾细胞癌组织，并通过免疫组织化学染色进行了分析。结果显示B7-H4与CCL20和CXCL8呈正相关，并验证了在肿瘤细胞系中鉴定的DEG。将786-O转染子接种到非肥胖型糖尿病/严重合并免疫缺陷小鼠中，并研究了肿瘤的生长。 B7-H4过表达促进肿瘤生长，抗CXCL8抗体的给药逆转了这一效应。此外，B7-H4过表达增加了肿瘤浸润中性粒细胞的数量，而对CXCL8的抑制则废除了这种作用。这些数据表明CXCL8在肿瘤微环境中募集嗜中性粒细胞在B7-H4的肿瘤促进作用中起重要作用。本研究揭示了B7-H4除促进T细胞外还具有促进肿瘤的新机制。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724376[0m

Title: MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: Cervical cancer (CC) is a common malignant tumor among women worldwide, remaining the fourth most frequent cause of cancer death in women. Currently, microRNA (miRNA) is a prevalent topic in tumor-related research. The present study focused on the mechanisms of miR-100 in CC progression. qRT-PCR analysis revealed that the miR-100 expression was notably decreased in CC tissues. In addition, miR-100 downregulation was confirmed to be significantly related to the malignant clinicopathologic features of CC patients. Furthermore, miR-100 overexpression was also verified to significantly repress CC cell proliferation, migration and invasion abilities through modulating the AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition. Bioinformatics analysis and luciferase reporter assay identified that special AT-rich sequence-binding protein 1 was a functional target for miR-100 in CC cells. Moreover, miR-100 overexpression was found to markedly repress the CC tumor growth <i>in vivo</i>. In conclusion, the above results revealed that miR-100 functioned as a cancer suppressor in CC progression and may provide insights into the novel therapeutic target for CC treatment.

Abstrct_CN: 宫颈癌（CC）是全世界女性中常见的恶性肿瘤，仍然是女性死于癌症的第四大原因。目前，microRNA（miRNA）是肿瘤相关研究中的一个普遍话题。本研究集中于miR-100在CC进展中的机制。 qRT-PCR分析显示，miR-100表达在CC组织中明显降低。此外，证实miR-100下调与CC患者的恶性临床病理特征显着相关。此外，还证实了miR-100的过表达可通过调节AKT / mTOR信号传导途径和上皮-间质转化来显着抑制CC细胞增殖，迁移和侵袭能力。生物信息学分析和荧光素酶报告基因分析鉴定出，富含AT的特殊序列结合蛋白1是CC细胞中miR-100的功能靶标。此外，发现miR-100过表达显着抑制体内CC肿瘤的生长。总之，以上结果表明，miR-100在CC进展中起癌症抑制作用，并可能为CC治疗的新型治疗靶点提供见识。

[1m[33m####################################################################################################[0m

[1m[31mPubmed ID: 32724363[0m

Title: Increased frequency of <i>ESR1</i> mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor.

Journal: Oncology letters (Oncol Lett)

Date: 2020-Aug

Abstrct_EN: In several recent studies on metastatic breast cancer (MBC), ligand binding domain mutations of the estrogen receptor, which is coded by the <i>ESR1</i> gene, were induced by long-term endocrine therapy and resulted in acquired endocrine therapy resistance and poor outcomes. Knowledge of the association between the development of <i>ESR1</i> mutation and the clinicopathologic features may guide the decision-making process of metastatic breast cancer treatment, including endocrine therapy. The aim of the present study was to evaluate the association between the development of <i>ESR1</i> mutation and the clinicopathologic characteristics of patients with MBC. To evaluate the association between the development of <i>ESR1</i> mutation and clinicopathologic features, a cohort of 22 patients with MBC were retrospectively analyzed using next generation sequencing. In 14 of 22 patients, four mutations were detected on the metastatic site, including Tyr537Ser, Glu542Asp, Leu536Arg and Arg548Cys. Univariate analysis demonstrated that the duration of aromatase inhibitor and selective estrogen receptor modulator treatment, as well as the age of treatment initiation for early-stage breast cancer, were significantly associated with the development of <i>ESR1</i> mutation. <i>ESR1</i> mutation was identified in all five patients who received selective estrogen receptor modulators in the adjuvant setting followed by aromatase inhibitors in the metastatic setting, as well as in two of the three patients who received no selective estrogen receptor modulators in adjuvant setting followed by aromatase inhibitors in the metastatic setting. In conclusion, the results of the present study suggested that administrating adjuvant selective estrogen receptor modulator followed by aromatase inhibitor for metastasis may increase the frequency of <i>ESR1</i> mutation.

Abstrct_CN: 在近期对转移性乳腺癌（MBC）的一些研究中，长期内分泌治疗诱导了<i> ESR1 </ i>基因编码的雌激素受体的配体结合域突变，并导致了获得性内分泌治疗抵抗力和不良结果。了解<i> ESR1 </ i>突变的发展与临床病理特征之间的关联可能会指导转移性乳腺癌治疗（包括内分泌治疗）的决策过程。本研究的目的是评估<i> ESR1 </ i>突变的发展与MBC患者临床病理特征之间的关系。为了评估<i> ESR1 </ i>突变的发展与临床病理特征之间的关系，采用下一代测序方法对22例MBC患者进行回顾性分析。在22例患者中的14例中，在转移部位检测到四个突变，包括Tyr537Ser，Glu542Asp，Leu536Arg和Arg548Cys。单因素分析表明，芳香酶抑制剂和选择性雌激素受体调节剂的治疗时间以及早期乳腺癌的治疗起始年龄与<i> ESR1 </ i>突变的发生密切相关。在辅助治疗中接受选择性雌激素受体调节剂，随后在转移性治疗中接受芳香酶抑制剂的所有五名患者中以及所有未接受选择性雌激素受体调节剂的三名患者中的两名中鉴定出了<i> ESR1 </ i>突变在佐剂环境中，其次是芳香酶抑制剂，在转移环境中。总之，本研究的结果表明，在转移后给予佐剂选择性雌激素受体调节剂和芳香酶抑制剂可能会增加<i> ESR1 </ i>突变的频率。

[1m[33m####################################################################################################[0m

